Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy

Area of Science:

• Cardiovascular Research
• Metabolomics
• Biochemistry

Background:

• Ischemic heart disease (IHD) is a condition of reduced blood supply to the heart muscle.
• Chronic ischemia can progress to ischemic cardiomyopathy (ICM), a serious cardiovascular disorder.
• Lipid alterations in IHD and ICM patients are not well-understood despite rising prevalence.

Purpose of the Study:

• To investigate and characterize the serum lipid profiles in patients with IHD and ICM.
• To identify specific circulating lipids that are significantly altered in these patient groups.
• To explore the potential of these lipid alterations as biomarkers or therapeutic targets.

Main Methods:

• A cross-sectional study design was employed.
• Serum lipid profiles were analyzed using a non-targeted lipidomics approach.
• Patients with IHD, ICM, and healthy controls were included in the analysis.

Main Results:

• A total of 125 lipids were detected across positive and negative ion modes.
• Several specific lipids (e.g., Lyso PI, Lyso PC, SM, PC) showed significant alterations in both IHD and ICM patients compared to controls.
• Additional lipids were found to be altered exclusively in ICM patients compared to both IHD and control groups.

Conclusions:

• Non-targeted lipidomics successfully identified distinct circulating lipid signatures in IHD and ICM.
• These identified lipid metabolic signatures hold promise as novel biomarkers for disease diagnosis and progression.
• The findings suggest potential new avenues for therapeutic interventions aimed at preventing and treating ischemic cardiomyopathy.